Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company ▾	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
ENLV	Enlivex Ltd. Manufacturing · Year ended 2025-12-31 · USD	n/a	$1.24B	n/a	63.9%	n/a	$25.48
ELVN	Enliven Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$103.69M	n/a	-22.6%	n/a	-$1.83
EMMA	Emmaus Life Sciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$12.45M	-$7.49M	-60.2%	n/a	-25.2%	-$0.12
EBS	Emergent BioSolutions Inc. Manufacturing · Year ended 2025-12-31 · USD	$742.90M	$52.60M	7.1%	10.1%	-28.8%	$0.93
ELTX	Elicio Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$39.57M	n/a	n/m	n/a	-$2.58
ELDN	Eledon Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$45.62M	n/a	-56.3%	n/a	-$0.52
ELAN	Elanco Animal Health Inc Manufacturing · Year ended 2025-12-31 · USD	$4.71B	-$232.00M	-4.9%	-3.5%	6.2%	-$0.47
EWTX	Edgewise Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$167.79M	n/a	-32.1%	n/a	-$1.63
EDSA	Edesa Biotech, Inc. Manufacturing · Year ended 2025-09-30 · USD	n/a	-$7.19M	n/a	-57.7%	n/a	n/a
ETST	Earth Science Tech, Inc. Manufacturing · Year ended 2026-03-31 · USD	$35.70M	$3.63M	10.2%	51.8%	7.8%	$0.012
XCUR	Exicure, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$4.95M	n/a	-126.0%	-100.0%	-$0.79
EPRX	Eupraxia Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$38.58M	n/a	-47.0%	n/a	-$1.03
ENTA	Enanta Pharmaceuticals Inc Manufacturing · Year ended 2025-09-30 · USD	$65.32M	-$81.89M	-125.4%	-126.5%	-3.4%	-$3.84
ELTP	Elite Pharmaceuticals Inc Manufacturing · Year ended 2026-03-31 · USD	$148.87M	$44.87M	30.1%	45.4%	77.1%	$0.03
LLY	Eli Lilly & Co Manufacturing · Year ended 2025-12-31 · USD	$65.18B	$20.64B	31.7%	77.8%	44.7%	$22.95
DYN	Dyne Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$446.21M	n/a	-45.9%	n/a	-$3.47
DWTX	Dogwood Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$34.26M	n/a	-45.7%	n/a	-$7.13
IRON	Disc Medicine, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$212.18M	n/a	-28.7%	n/a	-$6.01
DNTH	Dianthus Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.04M	-$162.34M	n/m	-32.9%	-67.3%	-$4.20
DMAC	DiaMedica Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$32.77M	n/a	-58.4%	n/a	n/a
DSGN	Design Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$69.79M	n/a	-32.8%	n/a	-$1.22
DRMA	Dermata Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$7.56M	n/a	-121.5%	n/a	-$8.16
DCOY	Decoy Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$12.52M	n/a	-212.6%	n/a	-$129.10
DARE	Dare Bioscience, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.03M	-$13.40M	n/m	-471.4%	n/m	-$1.20
DMRA	Damora Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$209.84M	n/a	-87.3%	n/a	$3.98

Rows per page: 2550 100